https://orcid.org/0000-0002-2435-7237
Citations (65)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Yingli Wu, Yu Yang, Xiaolin Lv, Menghan Gao, Xujin Gong, Qingqiang Yao & Yanna Liu. (2023) Nanoparticle-Based Combination Therapy for Ovarian Cancer. International Journal of Nanomedicine 18, pages 1965-1987.
Read now
Read now
Steve Harakeh, Saber H. Saber, Rajaa Al-Raddadi, Turki Alamri, Soad Al-Jaouni, Mohammed Qari, Yousef Qari, Shafiul Haque, Ayat Zawawi, Soad S. Ali, Zakaria Y. Abd Elmageed & Shaker Mousa. (2023) Novel curcumin nanoformulation induces apoptosis, and reduces migration and angiogenesis in liver cancer cells. Artificial Cells, Nanomedicine, and Biotechnology 51:1, pages 361-370.
Read now
Read now
Yu-Jia Wang, Ling Tang, Xu-Hong Lu, Ji-Tao Liu, Yuan-Yuan Wang, Hong-Xia Geng, Xue-Tao Li & Quan An. (2023) Efficacy of epi-1 modified epirubicin and curcumin encapsulated liposomes targeting-EpCAM in the inhibition of epithelial ovarian cancer cells. Journal of Liposome Research 33:2, pages 197-213.
Read now
Read now
Alistia Ilmiah Fahira, Riezki Amalia, Melisa Intan Barliana, Vesara Ardhe Gatera & Rizky Abdulah. (2022) Polyethyleneimine (PEI) as a Polymer-Based Co-Delivery System for Breast Cancer Therapy. Breast Cancer: Targets and Therapy 14, pages 71-83.
Read now
Read now
Mohammad Kashif Iqubal, Harsimran Kaur, Shadab Md, Nabil A. Alhakamy, Ashif Iqubal, Javed Ali & Sanjula Baboota. (2022) A technical note on emerging combination approach involved in the onconanotherapeutics. Drug Delivery 29:1, pages 3197-3212.
Read now
Read now
Bingqian Li, Huili Shao, Lei Gao, Huan Li, Huagang Sheng & Liqiao Zhu. (2022) Nano-drug co-delivery system of natural active ingredients and chemotherapy drugs for cancer treatment: a review. Drug Delivery 29:1, pages 2130-2161.
Read now
Read now
Malihe Mohamadian, Afsane Bahrami, Maryam Moradi Binabaj, Fereshteh Asgharzadeh & Gordon A. Ferns. (2022) Molecular Targets of Curcumin and Its Therapeutic Potential for Ovarian Cancer. Nutrition and Cancer 74:8, pages 2713-2730.
Read now
Read now
Gang Gui, Ziqi Fan, Yihuan Ning, Cancan Yuan, Baolin Zhang & Qin Xu. (2021) Optimization, Characterization and in vivo Evaluation of Paclitaxel-Loaded Folate-Conjugated Superparamagnetic Iron Oxide Nanoparticles. International Journal of Nanomedicine 16, pages 2283-2295.
Read now
Read now
Juan Li, Lei Zheng, Rongmei Wang, Deqing Sun, Shuang Liang, Jing Wu, Yongqing Liu, Xiaona Tian, Tingting Li, Yang Yang & Leiqiang Han. (2020) Synergistic Combination of Sodium Aescinate-Stabilized, Polymer-Free, Twin-Like Nanoparticles to Reverse Paclitaxel Resistance. International Journal of Nanomedicine 15, pages 5839-5853.
Read now
Read now
Ke Gong, Yang Dong, Liting Wang, Yi Duan, Jian Yu, Ying Sun, Min Bai & Yourong Duan. (2020) Nanoparticle BAF312@CaP-NP Overcomes Sphingosine-1-Phosphate Receptor-1-Mediated Chemoresistance Through Inhibiting S1PR1/P-STAT3 Axis in Ovarian Carcinoma. International Journal of Nanomedicine 15, pages 5561-5571.
Read now
Read now
Articles from other publishers (55)
Pingfu Huang, Hui Yan, Hao Wu, Lulu Liu, Wenmin Niu, Bo Zhai, Ziwei Hu, Jingjuan Li, Qianming Du & Yang Zhou. (2023) Application of curcumin as a co-former and an efflux inhibitor in paclitaxel co-amorphous mixture. Journal of Drug Delivery Science and Technology 84, pages 104513.
Crossref
Crossref
Jiang Yuxue, Sun Ran, Fan Minghui & Sheng Minjia. (2023) Applications of nanomaterials in endometriosis treatment. Frontiers in Bioengineering and Biotechnology 11.
Crossref
Crossref
Holya A. Lafta, Ali H. AbdulHussein, Saif A. J. Al-Shalah, Yasir S. Alnassar, Naseer M. Mohammed, Sally M. Akram, Maytham T. Qasim & Masoud Najafi. (2023) Tumor-associated Macrophages (TAMs) in Cancer Resistance; Modulation
by Natural Products. Current Topics in Medicinal Chemistry 23:12, pages 1104-1122.
Crossref
Crossref
Jianing Gong, Taoran Shi, Jinfeng Liu, Zerong Pei, Jingbo Liu, Xiaoliang Ren, Fengyun Li & Feng Qiu. (2023) Dual-drug codelivery nanosystems: An emerging approach for overcoming cancer multidrug resistance. Biomedicine & Pharmacotherapy 161, pages 114505.
Crossref
Crossref
Mohd Shahnawaz Khan, Nojood Altwaijry, Nasimudeen R. Jabir, Abdulaziz Mohammed Alamri, Mohammad Tarique & Azhar U. Khan. (2023) Potential of green-synthesized ZnO NPs against human ovarian teratocarcinoma: an in vitro study. Molecular Biology Reports 50:5, pages 4447-4457.
Crossref
Crossref
Pingyin Lee, Canquan Zhou & Xiaokun Hu. (2023) VX-765 has a Protective Effect on Mice with Ovarian Injury Caused by
Chemotherapy. Current Cancer Drug Targets 23:4, pages 307-318.
Crossref
Crossref
Peichun Peng, Zeshan Chen, Miaodong Wang, Bin Wen & Xin Deng. (2023) Polysaccharide‐modified liposomes and their application in cancer research. Chemical Biology & Drug Design 101:4, pages 998-1011.
Crossref
Crossref
Ching-Yee Loo, Daniela Traini, Paul M. Young, Thaigarajan Parumasivam & Wing-Hin Lee. (2023) Pulmonary delivery of curcumin and quercetin nanoparticles for lung cancer – Part 2: Toxicity and endocytosis. Journal of Drug Delivery Science and Technology 82, pages 104375.
Crossref
Crossref
Xiaoping Liu, Mingming Qi, Xidie Li, Jingjin Wang & Mingyuan Wang. (2023) Curcumin: a natural organic component that plays a multi-faceted role in ovarian cancer. Journal of Ovarian Research 16:1.
Crossref
Crossref
Pierre Idlas, Elise Lepeltier, Guillaume Bastiat, Pascal Pigeon, Michael J. McGlinchey, Nolwenn Lautram, Anne Vessières, Gerard Jaouen & Catherine Passirani. (2023) Physicochemical Characterization of Ferrocifen Lipid Nanocapsules: Customized Drug Delivery Systems Guided by the Molecular Structure. Langmuir 39:5, pages 1885-1896.
Crossref
Crossref
Wenhui Jia, Li Zhou, Lei Li, Ping Zhou & Zhisen Shen. (2023) Nano-Based Drug Delivery of Polyphenolic Compounds for Cancer Treatment: Progress, Opportunities, and Challenges. Pharmaceuticals 16:1, pages 101.
Crossref
Crossref
Mohamed T. El-Saadony, Tao Yang, Sameh A. Korma, Mahmoud Sitohy, Taia A. Abd El-Mageed, Samy Selim, Soad K. Al Jaouni, Heba M. Salem, Yasser Mahmmod, Soliman M. Soliman, Shaimaa A. A. Mo’men, Walid F. A. Mosa, Nahed A. El-Wafai, Hamed E. Abou-Aly, Basel Sitohy, Mohamed E. Abd El-Hack, Khaled A. El-Tarabily & Ahmed M. Saad. (2023) Impacts of turmeric and its principal bioactive curcumin on human health: Pharmaceutical, medicinal, and food applications: A comprehensive review. Frontiers in Nutrition 9.
Crossref
Crossref
Ngoc The Nguyen, Quynh Anh Bui, Phuong Duy Huynh, Quang Huy Nguyen, Ngoc Quyen Tran, Nguyen Thanh Viet & Dinh Trung Nguyen. (2022) Curcumin and Paclitaxel Co-loaded Heparin and Poloxamer P403 Hybrid Nanocarrier for Improved Synergistic Efficacy in Breast Cancer. Current Drug Delivery 19:9, pages 966-979.
Crossref
Crossref
Junlong Da, Ying Li, Kai Zhang, Junyu Ren, Jianqun Wang, Xinpeng Liu, Xiaoyao Liu, Jiahui Zhang, Lixue Liu, Wenxuan Zhang, Shujian Zhang, Yuyao Guo, Bin Zhang & Han Jin. (2022) Functionalized Prussian Blue Nanozyme as Dual-Responsive Drug Therapeutic Nanoplatform Against Maxillofacial Infection via Macrophage Polarization. International Journal of Nanomedicine Volume 17, pages 5851-5868.
Crossref
Crossref
Zahra AvanJavad Biabani ArdakaniFereshteh Talebpour AmiriSeyed Mohammad AbediSeyed Jalal Hosseinimehr. (2022)
The Potential Usefulness of
99m
Tc-HYNIC-(Ser)
3
-LTVPWY Peptide for Predicting HER2 Status Alteration After Chemotherapy in Ovarian Tumor-Bearing Mice
. Cancer Biotherapy and Radiopharmaceuticals 37:9, pages 862-869.
Crossref
Crossref
Xi Ye, Xin Chen, Ruixi He, Wangyang Meng, Weidong Chen, Fengling Wang & Xiangyun Meng. (2022) Enhanced anti-breast cancer efficacy of co-delivery liposomes of docetaxel and curcumin. Frontiers in Pharmacology 13.
Crossref
Crossref
Sruthi Sritharan, Sampurna Guha, Snoopy Hazarika & Nageswaran Sivalingam. (2022) Meta analysis of bioactive compounds, miRNA, siRNA and cell death regulators as sensitizers to doxorubicin induced chemoresistance. Apoptosis 27:9-10, pages 622-646.
Crossref
Crossref
Priya Yadav, Suresh V. Ambudkar & N. Rajendra Prasad. (2022) Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer. Journal of Nanobiotechnology 20:1.
Crossref
Crossref
Quan Gao, Jiao Feng, Wencheng Liu, Chengyong Wen, Yihan Wu, Qian Liao, Liang Zou, Xinbing Sui, Tian Xie, Jinming Zhang & Yichen Hu. (2022) Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment. Advanced Drug Delivery Reviews 188, pages 114445.
Crossref
Crossref
Muhammad Muzamil Khan & Vladimir P. Torchilin. (2022) Recent Trends in Nanomedicine-Based Strategies to Overcome Multidrug Resistance in Tumors. Cancers 14:17, pages 4123.
Crossref
Crossref
Maria Younes, Rita Mardirossian, Liza Rizk, Tia Fazlian, Jean Paul Khairallah, Christopher Sleiman, Hassan Y. Naim & Sandra Rizk. (2022) The Synergistic Effects of Curcumin and Chemotherapeutic Drugs in Inhibiting Metastatic, Invasive and Proliferative Pathways. Plants 11:16, pages 2137.
Crossref
Crossref
Mengdan Zhao, Meng Zhang, Qin Yu, Weidong Fei, Tiantian Li, Libo Zhu, Yao Yao, Caihong Zheng & Xinmei Zhang. (2022) Hyaluronic Acid-Modified Nanoplatforms as a Vector for Targeted Delivery of Autophagy-Related Gene to the Endometriotic Lesions in Mice. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Crossref
Riya Khetan, Cintya Dharmayanti, Todd A. Gillam, Eric Kübler, Manuela Klingler-Hoffmann, Carmela Ricciardelli, Martin K. Oehler, Anton Blencowe, Sanjay Garg & Hugo Albrecht. (2022) Using GPCRs as Molecular Beacons to Target Ovarian Cancer with Nanomedicines. Cancers 14:10, pages 2362.
Crossref
Crossref
Rui Gao, Yunfang Ma, Yali Wang & Haili Xu. (2022) Curcumin Inhibits the Proliferation of Renal Cancer 786-O Cells through MTOR Signaling Pathway and Its Mechanism. Journal of Healthcare Engineering 2022, pages 1-7.
Crossref
Crossref
Lijun Pang, Lei Zhang, Hong Zhou, Ling Cao, Yueqin Shao & Tengyun Li. (2022) Reactive Oxygen Species-Responsive Nanococktail With Self-Amplificated Drug Release for Efficient Co-Delivery of Paclitaxel/Cucurbitacin B and Synergistic Treatment of Gastric Cancer. Frontiers in Chemistry 10.
Crossref
Crossref
Lirong Zhang, Xiaodong Ma, Wenhui Zhou, Qiwei Wu, Jiaqi Yan, Xiaoyu Xu, Bhawana Ghimire, Jessica M. Rosenholm, Jing Feng, Dongqing Wang & Hongbo Zhang. (2022) Combination of photothermal, prodrug and tumor cell camouflage technologies for triple-negative breast cancer treatment. Materials Today Advances 13, pages 100199.
Crossref
Crossref
Solmaz Maleki Dizaj, Mahdieh Alipour, Elaheh Dalir Abdolahinia, Elham Ahmadian, Aziz Eftekhari, Haleh Forouhandeh, Yalda Rahbar Saadat, Simin Sharifi & Sepideh Zununi Vahed. (2022) Curcumin nanoformulations: Beneficial nanomedicine against cancer. Phytotherapy Research 36:3, pages 1156-1181.
Crossref
Crossref
Chengyuan Zhang, Xuemei Zhou, Hanyi Zhang, Xuanliang Han, Baijun Li, Ran Yang & Xing Zhou. (2022) Recent Progress of Novel Nanotechnology Challenging the Multidrug Resistance of Cancer. Frontiers in Pharmacology 13.
Crossref
Crossref
Junzheng Yang, Qi He, Yunhan Wang, Zhaofeng Pan, Gangyu Zhang, Jianming Liang, Lijun Su, Ailin Wang, Chuning Zeng, Haoran Luo, Lingyun Liu, Jianliang Li, Qiuhong Rao, Baohua Wang, Haibin Wang & Peng Chen. (2022) Gegen Qinlian Decoction ameliorates type 2 diabetes osteoporosis via IGFBP3/MAPK/NFATc1 signaling pathway based on cytokine antibody array. Phytomedicine 94, pages 153810.
Crossref
Crossref
Namrata Dwivedi & Priyanka Saha. 2022. Advances in Nanotechnology-Based Drug Delivery Systems. Advances in Nanotechnology-Based Drug Delivery Systems
321
342
.
Fatemeh Rezaei-Tazangi, Hossein Roghani-Shahraki, Mahdi Khorsand Ghaffari, Firoozeh Abolhasani Zadeh, Aynaz Boostan, Reza ArefNezhad & Hossein Motedayyen. (2021) The Therapeutic Potential of Common Herbal and Nano-Based Herbal Formulations against Ovarian Cancer: New Insight into the Current Evidence. Pharmaceuticals 14:12, pages 1315.
Crossref
Crossref
M. V. Popovych, Ya. R. Shalai, S. M. Mandzynets, N. E. Mitina, O. S. Zaichenko & A. M. Babsky. (2021) Effect of a novel thiazole derivative and its complex with polymeric carriers on the activity of antioxidant enzymes in murine lymphoma cells. Studia Biologica 15:4, pages 37-48.
Crossref
Crossref
Shreelaxmi Gavas, Sameer Quazi & Tomasz M. Karpiński. (2021) Nanoparticles for Cancer Therapy: Current Progress and Challenges. Nanoscale Research Letters 16:1.
Crossref
Crossref
Mengjie Li, Ling Lin, Tingting Guo, Yujian Wu, Jiayi Lin, Yuanyuan Liu, Ke Yang & Chenxia Hu. (2021) Curcumin Administered in Combination with Glu-GNPs Induces Radiosensitivity in Transplanted Tumor MDA-MB-231-luc Cells in Nude Mice. BioMed Research International 2021, pages 1-11.
Crossref
Crossref
Barbara Fraser, Alexandra E. Peters, Jessie M. Sutherland, Mingtao Liang, Diane Rebourcet, Brett Nixon & Robert J. Aitken. (2021) Biocompatible Nanomaterials as an Emerging Technology in Reproductive Health; a Focus on the Male. Frontiers in Physiology 12.
Crossref
Crossref
Jing Zhang, Kaili Hu, Liuqing Di, Penglong Wang, Zhidong Liu, Jinming Zhang, Pengfei Yue, Wantong Song, Jingwei Zhang, Tongkai Chen, Zuhua Wang, Yongtai Zhang, Xiaoying Wang, Changyou Zhan, Yung-Chi Cheng, Xiang Li, Quan Li, Jing-Yu Fan, Youqing Shen, Jing-Yan Han & Hongzhi Qiao. (2021) Traditional herbal medicine and nanomedicine: Converging disciplines to improve therapeutic efficacy and human health. Advanced Drug Delivery Reviews 178, pages 113964.
Crossref
Crossref
Yuping Jiang, Wei Meng, Lijuan Wu, Kai Shao, Lili Wang, Mengchao Ding, Jinsheng Shi & Xiaoying Kong. (2021)
Image‐Guided TME‐Improving Nano‐Platform for Ca
2+
Signal Disturbance and Enhanced Tumor PDT
. Advanced Healthcare Materials 10:19, pages 2100789.
Crossref
Crossref
Huiyan Sun, Limin Zhang, Wei Cheng, Fengxia Hao, Liyan Zhou & Qiang Li. (2021) Injectable Hydrogels in Repairing Central Nervous System Injuries. Advances in Materials Science and Engineering 2021, pages 1-11.
Crossref
Crossref
Shuting Zuo, Zhenyu Wang, Xianquan An, Jing Wang, Xiao Zheng, Dan Shao & Yan Zhang. (2021) Self-Assembly Engineering Nanodrugs Composed of Paclitaxel and Curcumin for the Combined Treatment of Triple Negative Breast Cancer. Frontiers in Bioengineering and Biotechnology 9.
Crossref
Crossref
Yan Liang, Ze-Yun Liu, Ping-Yu Wang, You-Jie Li, Ran-Ran Wang & Shu-Yang Xie. (2021) Nanoplatform-based natural products co-delivery system to surmount cancer multidrug-resistant. Journal of Controlled Release 336, pages 396-409.
Crossref
Crossref
Zhi-Qiang Zhao, Wei Song, Xue-Qin Yan, Jin-Hai Tang, Jun-Chen Hou, Dan-Dan Wang, Su-Jin Yang, Qian Zhang & Jian Zhang. (2021) Autophagy Modulation and Synergistic Therapy to Combat Multidrug Resistance Breast Cancer Using Hybrid Cell Membrane Nanoparticles. Journal of Biomedical Nanotechnology 17:7, pages 1404-1416.
Crossref
Crossref
Qi He, Junzheng Yang, Gangyu Zhang, Delong Chen, Meng Zhang, Zhaofeng Pan, Zihao Wang, Lijun Su, Jiaxu Zeng, Baohua Wang, Haibin Wang & Peng Chen. (2021) Sanhuang Jiangtang tablet protects type 2 diabetes osteoporosis via AKT-GSK3β-NFATc1 signaling pathway by integrating bioinformatics analysis and experimental validation. Journal of Ethnopharmacology 273, pages 113946.
Crossref
Crossref
Shani L. Levit & Christina Tang. (2021) Polymeric Nanoparticle Delivery of Combination Therapy with Synergistic Effects in Ovarian Cancer. Nanomaterials 11:4, pages 1048.
Crossref
Crossref
Qinhao Guo, Yong Wu, Xueqi Guo, Lijie Cao, Fei Xu, Haiyun Zhao, Jun Zhu, Hao Wen, Xingzhu Ju & Xiaohua Wu. (2021) The RNA-Binding Protein CELF2 Inhibits Ovarian Cancer Progression by Stabilizing FAM198B. Molecular Therapy - Nucleic Acids 23, pages 169-184.
Crossref
Crossref
Dariya Begum, Neha Merchant & Ganji Purnachandra Nagaraju. 2021. A Theranostic and Precision Medicine Approach for Female-Specific Cancers. A Theranostic and Precision Medicine Approach for Female-Specific Cancers
1
30
.
Milad Ashrafizadeh, Ali Zarrabi, Sima Orouei, Sedigheh Saberifar, Saeed Salami, Kiavash Hushmandi & Masoud Najafi. (2020) Recent advances and future directions in anti‐tumor activity of cryptotanshinone: A mechanistic review. Phytotherapy Research 35:1, pages 155-179.
Crossref
Crossref
Yuan Li, Yan Gao, Xi Zhang, Hongyan Guo & Huile Gao. (2020) Nanoparticles in precision medicine for ovarian cancer: From chemotherapy to immunotherapy. International Journal of Pharmaceutics 591, pages 119986.
Crossref
Crossref
Milad Ashrafizadeh, Ali Zarrabi, Farid Hashemi, Amirhossein Zabolian, Hossein Saleki, Morteza Bagherian, Negar Azami, Atefe Kazemzade Bejandi, Kiavash Hushmandi, Hui Li Ang, Pooyan Makvandi, Haroon Khan & Alan Prem Kumar. (2020) Polychemotherapy with Curcumin and Doxorubicin via Biological Nanoplatforms: Enhancing Antitumor Activity. Pharmaceutics 12:11, pages 1084.
Crossref
Crossref
Mohammed A. Alarjah, Mostafa H. Shahin, Firas Al-Azzah, Abdallah A. Alarjah & Ziad H. Omran. (2020) Concomitant analysis of dasatinib and curcuminoids in a pluronic-based nanoparticle formulation using a novel HPLC method. Chromatographia 83:11, pages 1355-1370.
Crossref
Crossref
Milad Ashrafizadeh, Ali Zarrabi, Maryam Hashemipour, Massoud Vosough, Masoud Najafi, Md Shahinozzaman, Kiavash Hushmandi, Haroon Khan & Hamed Mirzaei. (2020) Sensing the scent of death: Modulation of microRNAs by Curcumin in gastrointestinal cancers. Pharmacological Research 160, pages 105199.
Crossref
Crossref
Bo Yang, Anlin Hao & Lin Chen. (2020) Mirror siRNAs loading for dual delivery of doxorubicin and autophagy regulation siRNA for multidrug reversing chemotherapy. Biomedicine & Pharmacotherapy 130, pages 110490.
Crossref
Crossref
Jia-Yang Wang, Ya-Qi Song, Jing Peng & Hong-Lei Luo. (2020) Nanostructured Lipid Carriers Delivering Sorafenib to Enhance Immunotherapy Induced by Doxorubicin for Effective Esophagus Cancer Therapy. ACS Omega 5:36, pages 22840-22846.
Crossref
Crossref
Jun Wan, Jian Wang, Min Zhou, Zhanpeng Rao & Xiean Ling. (2020) A cell membrane vehicle co-delivering sorafenib and doxorubicin remodel the tumor microenvironment and enhance immunotherapy by inducing immunogenic cell death in lung cancer cells. Journal of Materials Chemistry B 8:34, pages 7755-7765.
Crossref
Crossref
Milad Ashrafizadeh, Ali Zarrabi, Farid Hashemi, Ebrahim Rahmani Moghadam, Fardin Hashemi, Maliheh Entezari, Kiavash Hushmandi, Reza Mohammadinejad & Masoud Najafi. (2020) Curcumin in cancer therapy: A novel adjunct for combination chemotherapy with paclitaxel and alleviation of its adverse effects. Life Sciences 256, pages 117984.
Crossref
Crossref
Yihan Yao, Yunxiang Zhou, Lihong Liu, Yanyan Xu, Qiang Chen, Yali Wang, Shijie Wu, Yongchuan Deng, Jianmin Zhang & Anwen Shao. (2020) Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance. Frontiers in Molecular Biosciences 7.
Crossref
Crossref